![Alon Lazarus](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alon Lazarus
Plus aucun poste en cours
Profil
Alon Lazarus formerly worked at Paros Bio, Inc., as Director, Reunion Neuroscience, Inc., as Director, Lutris Pharma Ltd., as Director, Werewolf Therapeutics, Inc., as Independent Director from 2019 to 2024, Entact Bio, Inc., as Director, Photys Therapeutics, Inc., as Director, Auron Therapeutics, Inc., as Director, Pantheon Biosciences Ltd., as Director, Keros Therapeutics, Inc., as Independent Director from 2016 to 2020, Quiet Therapeutics Ltd., as Director, Oncorus, Inc., as Director from 2016 to 2019, Entact Bio Ltd., as Director from 2019 to 2023, Arkin Bio Ventures, as Biotech Investment Manager from 2013 to 2024, Yissum Holdings Ltd., as Head-Business Development from 2012 to 2013, Arkin Holdings, as Manager-Biotech Investment, and Integra Holdings Ltd., as Analyst.
Dr. Lazarus received his doctorate degree from The Hebrew University Hadassah Medical School and undergraduate degree and Masters Business Admin degree from The Hebrew University of Jerusalem.
Anciens postes connus de Alon Lazarus
| Sociétés | Poste | Fin |
|---|---|---|
Lutris Pharma Ltd.
 Lutris Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that improves anti cancer therapy effectiveness | Directeur/Membre du Conseil | 01/12/2024 |
| WEREWOLF THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/12/2024 |
Arkin Bio Ventures
 Arkin Bio Ventures Investment ManagersFinance Arkin Bio focuses its investment efforts in life science companies located across the globe, mainly in Israel. The firm targets businesses operating in the biotechnology and pharmaceutical sector. It provides financing for early to mid-stage capital requirements. | Private Equity Investor | 01/12/2024 |
Auron Therapeutics, Inc.
 Auron Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which cure cancer by radically changing the paradigm of cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells | Directeur/Membre du Conseil | 01/12/2024 |
Photys Therapeutics, Inc.
 Photys Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops proprietary bifunctional molecule therapeutics | Directeur/Membre du Conseil | 01/12/2024 |
Formation de Alon Lazarus
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yissum Holdings Ltd. | |
Quiet Therapeutics Ltd.
 Quiet Therapeutics Ltd. Medical SpecialtiesHealth Technology Develops a proprietary nanoparticle-based delivery system for the targeted delivery of chemotherapy and anti-inflammatory drugs | Health Technology |
Integra Holdings Ltd.
 Integra Holdings Ltd. MiscellaneousMiscellaneous Operates as a holding company | Miscellaneous |
The Hebrew University Hadassah Medical School
 The Hebrew University Hadassah Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncorus, Inc.
 Oncorus, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops next generation immunotherapy platform to treat cancer | Health Technology |
Keros Therapeutics, Inc.
 Keros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for muscle diseases | Health Technology |
Arkin Bio Ventures
Arkin Bio Ventures Investment ManagersFinance Arkin Bio focuses its investment efforts in life science companies located across the globe, mainly in Israel. The firm targets businesses operating in the biotechnology and pharmaceutical sector. It provides financing for early to mid-stage capital requirements. | Finance |
Auron Therapeutics, Inc.
Auron Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which cure cancer by radically changing the paradigm of cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells | Commercial Services |
Lutris Pharma Ltd.
Lutris Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that improves anti cancer therapy effectiveness | Health Technology |
Werewolf Therapeutics, Inc.
 Werewolf Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer | Health Technology |
Arkin Holdings
 Arkin Holdings Real Estate Investment TrustsFinance Provides healthcare investment services | Finance |
Locki Therapeutics Ltd.
 Locki Therapeutics Ltd. BiotechnologyHealth Technology Develops cancer immune therapy | Health Technology |
Pantheon Biosciences Ltd.
 Pantheon Biosciences Ltd. Miscellaneous Commercial ServicesCommercial Services Develops molecular therapies and tools | Commercial Services |
Photys Therapeutics, Inc.
Photys Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops proprietary bifunctional molecule therapeutics | Commercial Services |
Reunion Neuroscience, Inc.
 Reunion Neuroscience, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops FDA-approved serotonergic psychedelic therapeutic solutions for underserved mental health disorders | Health Technology |
Paros Bio, Inc.
 Paros Bio, Inc. BiotechnologyHealth Technology Engages in developing transformative gene therapies for the treatment of autosomal-dominant Alzheimer's disease | Health Technology |
Entact Bio, Inc.
 Entact Bio, Inc. BiotechnologyHealth Technology Develops medicines for increasing protein function | Health Technology |
